Future work in urology may look at factors influencing pursuit of the field
April 18th 2024"We can also look at the timing of exposure to urology. Does early exposure spark interest in urology, or does delayed introduction to the field hinder the consideration of the specialty?" says Ashley Appleton.
Expert discusses meta-analysis of prostate radiotherapy
April 18th 2024"In my view, at present in patients that have low-volume oligometastatic de novo metastatic prostate cancer, it's really an unknown whether comprehensive SBRT or other local therapy directed at oligomets improves survival," says Scott Morgan, MD, MSc, FRCPC.
Dr. Salari on family history, germline genetic risk in favorable-risk prostate cancer
April 16th 2024"What we found is that over a third of patients, 36%, had positive family history of either prostate, breast, or pancreatic cancer. And if you had this type of a family history, there was nearly a two-fold risk of dying of prostate cancer in the long term," says Keyan Salari, MD, PhD.
Study highlights need to recruit and retain URiM urologists
April 12th 2024"At the medical student level, we can provide early exposure to urology to make sure that these students feel properly equipped to apply to urology when that time comes and get adequate exposure to the field," says Ashley Appleton.
Dr. Morgan discusses guideline for salvage therapy in prostate cancer
April 11th 2024"There have been some pivotal clinical trials that have reported out, and they've really showed us that there is limited to maybe no role for adjuvant treatment after prostatectomy, and there is a huge role for early salvage treatment," says Todd M. Morgan, MD.
Recent data highlight importance of screening for prostate cancer in transgender women
April 10th 2024"I think the main takeaway from this study is that prostate cancer is not as rare in trans women as we think it is, and that we really need to be giving this population the time that they deserve, and that they should be screened equally to their cis male counterparts," says Matthew Loria.